Beauty Health CO Form 4 insider transactions

Michael P. Monahan, Chief Financial Officer of Beauty Health Co, reported a transaction in 32,357 shares of common stock on August 10, 2026.

Sheri Lewis, CSO and COO of Beauty Health Co, reported a transaction involving the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Michael P. Monahan, Chief Financial Officer of The Beauty Health Company, reported a transaction involving Class A Common Stock.

Pedro Bruno Ferreira Malha, President and CEO of The Beauty Health Company, received a grant of 2,654,867 restricted stock units.

The Beauty Health Company's CFO, Michael P. Monahan, was granted 746,681 Restricted Stock Units, vesting over three years.

The Beauty Health Company's Chief Revenue Officer, Ronald Menezes, was granted 746,681 restricted stock units vesting over three years.

Beauty Health Company's CSO and COO, Sheri Lewis, was granted 746,681 restricted stock units, vesting over three years.

Beauty Health Co's CSO and COO, Sheri Lewis, had 51,883 shares of Class A Common Stock withheld by the issuer to cover tax obligations related to restricted stock unit vesting.

The Beauty Health Company's Chief Revenue Officer, Ronald Menezes, reported the withholding of 61,471 shares for tax obligations related to restricted stock unit vesting.

Beauty Health Company's CFO, Michael P. Monahan, reported a disposition of 58,573 shares for tax withholding purposes related to restricted stock unit vesting.

Philippe Schaison, a director at The Beauty Health Company, was granted 57,692 restricted stock units vesting based on continued service.

Beauty Health Company's Chief Revenue Officer, Ronald Menezes, had 46,426 shares withheld for tax purposes upon the vesting of restricted stock units.

Beauty Health Company's President and CEO, Pedro Bruno Ferreira Malha, received a grant of 2,190,384 restricted stock units vesting over three years.

Beauty Health Company's CFO, Michael Monahan, had 32,357 shares withheld for tax obligations related to restricted stock unit vesting.

The Beauty Health Company's Director, Desiree Gruber, was granted 73,051 restricted stock units (RSUs) on June 16, 2025, as part of her compensation.

Brent L. Saunders, Chairman and Director of The Beauty Health Company, was granted 73,051 restricted stock units, increasing his beneficial ownership.

Michelle C. Kerrick, a Director of The Beauty Health Company, was granted 73,051 Class A Common Stock shares in the form of Restricted Stock Units on June 16, 2025, increasing her direct beneficial ownership to 189,813 shares.

Brian Christopher Miller, a director at The Beauty Health Company, was granted 73,051 restricted stock units, increasing his beneficial ownership to 243,035 shares.

Doug K. Schillinger, a Director at The Beauty Health Company, was granted 73,051 Restricted Stock Units (RSUs) on June 16, 2025, aligning his interests with shareholders.

Stephen J. Fanning, a Director of The Beauty Health Company, was granted 73,051 Class A Common Stock Restricted Stock Units, increasing his beneficial ownership to 527,283 shares.

The Beauty Health Company's Chief Financial Officer, Michael P. Monahan, reported a disposition of 24,290 shares of Class A Common Stock on June 1, 2025, primarily for tax withholding purposes related to restricted stock unit vesting.

Beauty Health Company's CFO, Michael P. Monahan, had 26,776 shares withheld by the issuer to cover tax obligations related to restricted stock unit vesting.

Sheri Lewis, CSO and COO of Beauty Health Co., reports disposition of shares to cover tax obligations upon vesting of restricted stock units.

Marla Malcolm Beck, President and CEO of Beauty Health Co, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Sheri Lewis, CSO and COO of Beauty Health Co., reports acquiring Class A Common Stock through a grant of restricted stock units.

Chief Revenue Officer Ronald Menezes of Beauty Health Co. was granted restricted stock units on March 17, 2025, according to a Form 4 filing.

Marla Malcolm Beck, President and CEO of Beauty Health Co., reports the acquisition of restricted stock units.

Michael Monahan, CFO of Beauty Health Co, reports acquiring Class A Common Stock through a grant of restricted stock units.

Michael Monahan, Chief Financial Officer of Beauty Health Co., reported a transaction involving the withholding of shares to cover tax obligations.

Director Desiree Gruber sold 14,663 shares of Beauty Health Co. at a price of $1.5019 per share on November 20, 2024.